ITGA2 has been identified as a key downstream target of BMI1 in CD133+ glioblastoma stem cells (GBM-SCs), regulating the characteristics of GBM stem cells (Vora et al., 2019). The gene discussed is ITGA2; the disease is glioblastoma.